Biodesix, Inc. BDSX
Set alert
21.78 USD 0.00 0.00%
At close · Nov 2
21.78 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
Day range unavailable
5.26 52-week range 31.97
- YTD
- +220.29%
- 1 year
- +218.89%
- Open
- —
- Prev close
- 21.78
- Mkt cap
- 229.80M
- Vol
- 0
- Avg vol
- 104.41K
- EPS
- -3.10
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -6.64
- Beta
- 1.21
- Short ratio
- 0.83
- Inst. own
- 42.83%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.43
- 200-d avg
- 1.53
- 1y target
- 3.10
6M chart
Signals (25)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 4 days ago |
| SMA: Bullish | Oct 29, 2026 | 5 days ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| SMA: Bearish | Oct 8, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 1, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 23, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 22, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 17, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| RSI: Overbought | Aug 26, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 21, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 20, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 19, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 18, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 10, 2026 | 3 months ago |
| RSI: Overbought | Jun 25, 2026 | 4 months ago |
| RSI: Overbought | Jun 23, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 18, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 8, 2026 | 4 months ago |
Newest 20 of 25.
Analyst view
Consensus: none
Price target (mean) 3.10 -85.8% downside
Now 21.78
- Target (low)
- 3.00
- Target (mean)
- 3.10
- Target (high)
- 3.50
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 19.83M | +35.2% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 20.22M | +36.5% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 70.73M | +44.1% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 92.25M | +30.4% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 16, 2024 | Scotiabank | Initiated | — | Sector Outperform |
| Jul 26, 2024 | Craig-Hallum | Initiated | — | Buy |
| May 13, 2024 | TD Cowen | Initiated | — | Buy |
| May 3, 2024 | Lake Street | Initiated | — | Buy |
| Mar 4, 2024 | Canaccord Genuity | Reiterated | Buy | Buy |
| Dec 7, 2023 | Canaccord Genuity | Reiterated | Buy | Buy |
| May 12, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Apr 20, 2022 | Cowen & Co. | Initiated | — | Outperform |
| Nov 17, 2021 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| May 12, 2021 | Morgan Stanley | Maintained | — | Overweight |
| Mar 18, 2021 | Morgan Stanley | Maintained | — | Overweight |
| Feb 2, 2021 | Canaccord Genuity | Maintained | — | Buy |
| Nov 23, 2020 | William Blair | Initiated | — | Outperform |
| Nov 23, 2020 | BTIG | Initiated | — | Buy |
| Nov 23, 2020 | Morgan Stanley | Initiated | — | Overweight |